Related Experiment Video

Updated: Aug 23, 2025

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

11.0K

Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations

Maria Ascencion Globisch1, Favour Chinyere Onyeogaziri1, Ross Osborne Smith1

  • 1Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.

International Journal of Molecular Sciences
|October 27, 2022
PubMed

Insights

Cerebral cavernous malformations (CCM) are increasingly viewed as a hemostatic disease. Research highlights the role of blood components and neuroinflammation in CCM development and severity, suggesting new therapeutic avenues.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Hematology

Background:

  • Cerebral cavernous malformation (CCM) affects 0.5% of the population.
  • Historically, CCM research focused on genetic mutations and endothelial cell biology.
  • Recent studies reveal crucial roles for the hemostatic system and neuroinflammation in CCM.

Purpose of the Study:

  • To review the latest molecular insights into CCM pathogenesis.
  • To explore the interaction between CCM-deficient endothelial cells, blood components, and the neurovascular unit.
  • To underscore the link between endothelial dysfunction and CCM-related symptoms.

Main Methods:

  • Comprehensive literature review.
  • Analysis of transcriptome and proteome studies.
  • Focus on molecular mechanisms and clinical implications.

Main Results:

  • Endothelial dysfunction in CCM leads to dysregulated hemostasis.
  • Bleeding, hypoxia, and neurological symptoms are linked to endothelial dysfunction.
  • CCM is increasingly recognized as a disease involving the hemostatic system.

Conclusions:

  • CCM pathogenesis involves complex interactions between endothelial cells and blood components.
  • The hemostatic system plays a critical role in CCM development and severity.
  • Viewing CCM as a hemostatic disease may open new therapeutic strategies.

Keywords:
BBBCCMNETosisbleedingcoagulationendotheliumhemostasishypoxiaimmunothrombosisneuroinflammation

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K
Ferric Chloride-induced Murine Thrombosis Models10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.9K

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
849
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
26
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
48.0K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18